Sign in

CIK 0001690585

  • Non-accelerated filer
  • Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,717,056
in 3 filings, $15.7M under 10b5-1 plans

Net −$15,717,056. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-12 Garcia Marino CEO AND PRESIDENT Sale 10b5-1 −43,505 $80.69 $3.5M 79,413
2026-03-12 Garcia Marino CEO AND PRESIDENT Sale 10b5-1 −65,517 $81.74 $5.4M 13,896
2026-03-12 Garcia Marino CEO AND PRESIDENT Sale 10b5-1 −12,796 $82.60 $1.1M 1,100
2026-03-12 Garcia Marino CEO AND PRESIDENT Sale 10b5-1 −200 $83.38 $17K 900
2026-03-12 Garcia Marino CEO AND PRESIDENT Sale 10b5-1 −900 $85.53 $77K 0
2026-03-12 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −15,852 $80.71 $1.3M 27,830
2026-03-12 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −23,465 $81.75 $1.9M 4,365
2026-03-12 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −3,865 $82.66 $319K 500
2026-03-12 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −200 $83.38 $17K 300
2026-03-12 CARR EDWARD CHIEF ACCOUNTING OFFICER Sale 10b5-1 −300 $85.53 $26K 0
2025-12-04 Savitz Ryan CFO & CBO Sale 10b5-1 −20,000 $45.18 $904K 0
2025-11-14 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −109,031 $38.14 $4.2M 4,000
2025-11-13 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −26,166 $35.80 $937K 65,341
2025-11-13 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −42,765 $37.04 $1.6M 22,576
2025-11-13 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −18,576 $37.72 $701K 4,000
2025-09-09 Savitz Ryan CFO & CBO Sale 10b5-1 −20,000 $35.00 $700K 0
2023-02-08 Third Rock Ventures IV, L.P. 10% owner Sale −1,500,000 $0.82 $1.2M 3,058,204
2023-02-07 Third Rock Ventures IV, L.P. 10% owner Sale −2,200,000 $0.83 $1.8M 4,558,204
2021-09-16 Stants Kristen Chief People Officer Sale −5,736 $6.73 $39K 14,264
2021-09-16 Mahoney Stephen F. Sale −5,736 $6.73 $39K 14,264

Page 4 of 6 · 119 trades